Trade groups say the law's broad criteria could restrict access to supplements with uses beyond weight loss or muscle building.
News|Articles|May 4, 2026
The Science Behind Brain-Targeted Magnesium
Author(s)AIDP
While magnesium plays a critical role in more than 300 cellular processes in the body, most conventional forms struggle to reach the brain due to the protective blood–brain barrier. Developed to overcome this challenge, Magnesium L-threonate (Magtein®) is advancing the science behind magnesium and cognitive longevity. Dr. Rafea Naffa, Ph.D., Director of R&D at Threotech, sat with Nutritional Outlook to explain the science behind this patented and unique form of magnesium and how it helps elevate brain magnesium healthy levels to support neuroplasticity and synaptic density. He also discusses the potential of brain-targeted magnesium supplementation to promote cognitive vitality, mental energy, and healthy brain aging.
Related to this article
At The Outlook on Active Nutrition, Doug Kalman, PhD, RD, FISSN, outlines where GLP-1 drugs are falling short, and where nutraceutical brands can step in.
At The Outlook on Active Nutrition, Michelle Arent, RD, MPH, CSCS, CISSN, director of Olympic sports performance nutrition at the University of South Carolina, tells attendees that vague testing language is putting college athletes at risk, and called on supplement brands to build clearer, more transparent partnerships with universities and practitioners.
The retail commercialization firm outlines its post-event strategy for emerging and international wellness brands entering the U.S. market, following the ECRM Vitamin, Weight Management & Sports Nutrition Session.
In the ninth episode, Nicholas and Lana unpack several longevity launches making waves, and why regulatory clearance, novelty, and clinical data are 3 separate things brands shouldn't blur together.
Part 2 of our interview with Todd Harrison, co-chair of the FDA practice group at Venable LLP covers preclusion's structural gaps: no defined end point, no tracking registry, and a push for mandatory drug-sponsor engagement.
Todd Harrison, co-chair of the FDA practice group at Venable LLP, details the Dietary Supplement Innovation Act's language, its unintended consequences, and what industry stakeholders should watch for.
The company's newest chewable concepts pair postbiotics with biotin and vitamin D3 to support skin, hair, and immune health.
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
California Governor Signs AB 2030, Restricting Minors' Access to Diet Supplements
2
Muscle Loss, Micronutrient Gaps, and the GLP-1 Opportunity for Supplement Brands
3
"Third-Party Tested" Isn't Good Enough, Sports Dietitian Tells Supplement Brands
4
Let's Talk Nutrition With Nico Episode 9: What the New NMN and Sleep Research Actually Shows
5